Company intelligence / Profile preview
Shandong Kangzhonghong Pharmaceutical Technology Development
- Ownership
- Private
- Development stage
- Phase 3
Overview
Shandong Kangzhonghong Pharmaceutical Technology Development is a private Chinese pharmaceutical company focused on the development of herbal medicines for infectious diseases, immune system diseases, and respiratory diseases. Its lead programs include Bimin Capsule (for perennial allergic rhinitis), Kemin Capsule (for cough), both in Phase 3 trials, and Xiao'er Qingzhen Oral Liquid (for hand, foot and mouth disease) in Phase 2[4]. The company has at least four herbal drug candidates in its pipeline.
- Therapeutic areas
- PulmonologyImmunologyInfectious Diseases
- Modalities
- Herbal medicine
- Industry
- Biotech
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Shandong Kangzhonghong Pharmaceutical Technology Development.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shandong Kangzhonghong Pharmaceutical Technology Development.